Lawrence B. Lachman - Concepedia

Author

Lawrence B. Lachman

The University of Texas MD Anderson Cancer Center

Also Known As

L B Lachman, L. B. LACHMAN, L. B. Lachman, L.B. Lachman, LAWRENCE B. LACHMAN, Lawrence B Lachman, Lawrence B. Lachman

Publications

Citations

H-Index

101

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Anderson Hospital Duke Medical Center Duke University Duke University Hospital

About

Lawrence B. Lachman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	30	4.1K
2	Health Sciences	2	2	423
3	Engineering	1	1	23
4	Natural Sciences	1	1	16
5	Social Sciences	1	1	856

Lawrence B. Lachman

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Interleukin-1 Stimulation of Astroglial Proliferation After Brain Injury Dana Giulian, Lawrence B. Lachman Science Traumatic Brain InjuryImmunologyCell DeathGliomaSocial Sciences	1985	856
The functional relationship of the interleukins. Kevin M. Smith, Lawrence B. Lachman, Joost J. Oppenheim, The Journal of Experimental Medicine T-regulatory CellImmunologyImmune RegulationImmunologic MechanismT Cells	1980	653
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. Jonathan Kaye, Steven Gillis, S B Mizel, The Journal of Immunology	1984	521
Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. G.J. Darlington, Debra Rose Wilson, Lawrence B. Lachman The Journal of Cell Biology Monocyte-conditioned MediumImmunologyImmune RegulationPathologyBlood Cell	1986	400
Interleukin 1 stimulation of collagenase production by cultured fibroblasts. Arnold E. Postlethwaite, Lawrence B. Lachman, Carlo L. Mainardi, The Journal of Experimental Medicine ImmunologyImmune RegulationCell CultureDermatologyCellular Physiology	1983	370
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. Elizabeth A. Grimm, R J Robb, Jack A. Roth, The Journal of Experimental Medicine ImmunologyImmunologic MechanismImmune SystemImmunotherapyNatural Killer Cells	1983	354
Natural and recombinant human interleukin 1-<i>beta</i> is cytotoxic for human melanoma cells. Lawrence B. Lachman, Charles A. Dinarello, Norma Llansa, The Journal of Immunology	1986	202
Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. Lawrence B. Lachman, Dale C. Brown, Charles A. Dinarello The Journal of Immunology ImmunotoxicologyImmunologyImmune RegulationCell DeathImmunologic Mechanism	1987	164
Induction of fibroblast proliferation by interleukin‐1 derived from human monocytic leukemia cells Arnold E. Postlethwaite, Lawrence B. Lachman, Andrew H. Kang Arthritis & Rheumatism	1984	124
Partial Purification of Human Lymphocyte-Activating Factor (LAF) by Ultrafiltration and Electrophoretic Techniques Lawrence B. Lachman, Miles P. Hacker, Robert E. Handschumacher The Journal of Immunology Laf ActivityImmunologyProtein PurificationBioanalysisAnalytical Chemistry	1977	124

Page 1